Addus HomeCare Stock Analysis, Valuation (NASDAQ:ADUS)
Addus HomeCare Analysis Video
View Addus HomeCare stock analysis video. This is our ADUS analyst opinion covering the buy and sell arguments for ADUS stock.
Addus Homecare Corporation Stock Rating (3.6/5)
Our Addus HomeCare stock opinion is based on fundamentals of the company. This Addus HomeCare stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.
Should you buy ADUS stock?
- The TTM operating margin was good at 5.6% for Addus HomeCare.
- ADUS stock is trading at a favorable price to sales multiple of 1 as against the Medical-Outpatient-Home care industry average multiple of 5.
- Addus HomeCare generates a high return on invested capital of 9.8%.
- The LTM ROE of 10.3% for Addus HomeCare is attractive.
Should you sell ADUS stock?
- The company has a negative free cash flow margin of -20.9%.